AbstractBackgroundTranscatheter closure of various congenital and acquired vascular malformations with Amplatzer Vascular plugs I and II has been established. Here we present our experience with device closure.Materials and methodsBetween October 2006 and August 2012, nine (three males and six females) patients aged between 11 months and 62 years (mean age 19 years) underwent percutaneous device closure with AVP I and II vascular plugs for congenital and acquired arteriovenous malformation and cardiac diverticulum are presented here.ResultsOne case of coronary cameral fistula, four cases of pulmonary arteriovenous fistula, one case of large major aortopulmonary collaterals (in tetralogy of Fallot closed before intracardiac repair), one case...
ObjectiveUse of the Amplatzer vascular plug (AVP; St. Jude Medical Inc, St. Paul, Minn) for percutan...
OBJECTIVE: A case series on different vascular malformations (VM) treated with percutaneous occlusi...
PURPOSE:Occlusion time (OT) is an important factor in the treatment of pulmonary arteriovenous malfo...
AbstractBackgroundTranscatheter closure of various congenital and acquired vascular malformations wi...
The Amplatzer Vascular Plugs (AVP) are self-expandable devices made from a nitinol wire mesh that ha...
AbstractVascular plugs are ideally suited to close extra-cardiac, high flowing vascular communicatio...
We report our experience with the use of AMPLATZER?? Vascular Plug for the closure of coronary arter...
Artículo de publicación ISIIntroductionTranscatheter patent ductus arteriosus (PDA) closure is diffi...
WOS: 000333809600009PubMed ID: 24047719The Amplatzer (R) Vascular Plug (AVP) can be used to embolize...
OBJECTIVE: The purpose of this study was to report the authors' preliminary experience using the Amp...
Congenital coronary arteriovenous fistulas (CCAFs) are rare coronary artery abnormalities in which b...
Background: Transcatheter treatment has become the method of choice for treating many heart defects....
Introduction: Transcatheter patent ductus arteriosus (PDA) closure is difficult in small patients in...
The purpose of this study was to present our initial experience with the Amplatzer (R) Vascular Plug...
Vascular plugs are ideally suited to close extra-cardiac, high flowing vascular communications. The ...
ObjectiveUse of the Amplatzer vascular plug (AVP; St. Jude Medical Inc, St. Paul, Minn) for percutan...
OBJECTIVE: A case series on different vascular malformations (VM) treated with percutaneous occlusi...
PURPOSE:Occlusion time (OT) is an important factor in the treatment of pulmonary arteriovenous malfo...
AbstractBackgroundTranscatheter closure of various congenital and acquired vascular malformations wi...
The Amplatzer Vascular Plugs (AVP) are self-expandable devices made from a nitinol wire mesh that ha...
AbstractVascular plugs are ideally suited to close extra-cardiac, high flowing vascular communicatio...
We report our experience with the use of AMPLATZER?? Vascular Plug for the closure of coronary arter...
Artículo de publicación ISIIntroductionTranscatheter patent ductus arteriosus (PDA) closure is diffi...
WOS: 000333809600009PubMed ID: 24047719The Amplatzer (R) Vascular Plug (AVP) can be used to embolize...
OBJECTIVE: The purpose of this study was to report the authors' preliminary experience using the Amp...
Congenital coronary arteriovenous fistulas (CCAFs) are rare coronary artery abnormalities in which b...
Background: Transcatheter treatment has become the method of choice for treating many heart defects....
Introduction: Transcatheter patent ductus arteriosus (PDA) closure is difficult in small patients in...
The purpose of this study was to present our initial experience with the Amplatzer (R) Vascular Plug...
Vascular plugs are ideally suited to close extra-cardiac, high flowing vascular communications. The ...
ObjectiveUse of the Amplatzer vascular plug (AVP; St. Jude Medical Inc, St. Paul, Minn) for percutan...
OBJECTIVE: A case series on different vascular malformations (VM) treated with percutaneous occlusi...
PURPOSE:Occlusion time (OT) is an important factor in the treatment of pulmonary arteriovenous malfo...